4//SEC Filing
Stahl Maria D 4
Accession 0001209191-19-044241
CIK 0001373707other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:16 PM ET
Size
10.3 KB
Accession
0001209191-19-044241
Insider Transaction Report
Form 4
Stahl Maria D
SVP and General Counsel
Transactions
- Award
Common Stock
2019-04-02+13,913→ 37,611 total - Award
Restricted Stock Units
2019-08-01+57,000→ 57,000 total→ Common Stock (57,000 underlying) - Award
Restricted Stock Units
2019-08-01+18,000→ 18,000 total→ Common Stock (18,000 underlying)
Footnotes (4)
- [F1]On April 2, 2018, the Reporting person was granted 40,000 restricted stock units ("RSUs")( the "2018 RSU grant") that were previously reported on Table II Of Form 4, which form was filed with the Securities and Exchange Commission on April 4, 2018. Of the 2018 RSU grant, 20,000 shares vested on April 2, 2019 of which 6,087 shares were withheld by the Issuer to satisfy the reporting person's tax withholding obligations in connection with the delivery of the conversion of the RSUs into common stock on the vesting date. The total number of shares beneficially owned by the reporting person includes the 13,913 RSUs converted into shares of common stock of the Issuer on the April 2019 vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F3]The restricted stock units shall be eligible to be earned upon achievement of certain performance conditions and, if such conditions are met, shall vest no earlier than August 1, 2020 and no later than August 1, 2021.
- [F4]The restricted stock units vest in three equal installments on each of August 1, 2020, August 1, 2021 and August 1, 2022.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeother
Related Parties
1- filerCIK 0001494425
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:16 PM ET
- Size
- 10.3 KB